The intricate world of pharmaceutical synthesis relies on specific chemical building blocks, each with unique structural features that dictate their utility. (1R,2R)-1,2-Cyclohexanedicarboxylic Acid, identified by its CAS number 46022-05-3, is a prime example of such a crucial intermediate. Its defined stereochemistry and functional groups make it indispensable in the production of certain Active Pharmaceutical Ingredients (APIs), most notably Lurasidone.

Chemically, (1R,2R)-1,2-Cyclohexanedicarboxylic Acid is a dicarboxylic acid derived from cyclohexane. The designation '(1R,2R)' refers to the specific spatial arrangement of the carboxyl groups attached to the cyclohexane ring, indicating a precise chiral configuration. This stereospecificity is not merely a technical detail; it is fundamental to its function in API synthesis. Many biological processes, including drug-receptor interactions, are highly sensitive to molecular shape and chirality. Using the incorrect stereoisomer of an intermediate can lead to an API with reduced efficacy, altered pharmacological profiles, or even unwanted side effects.

The two carboxyl groups (-COOH) on the cyclohexane ring of CAS 46022-05-3 are reactive functional groups that can participate in various chemical transformations. In the synthesis of Lurasidone, this intermediate typically undergoes further reactions, such as esterification or amide formation, to build the complex molecular structure required for the API. The cyclohexane ring itself provides a stable, relatively rigid scaffold that helps orient these functional groups correctly for subsequent synthetic steps.

For pharmaceutical chemists and manufacturers, understanding the chemical structure and the significance of chirality in intermediates like (1R,2R)-1,2-Cyclohexanedicarboxylic Acid is paramount. It informs the selection of synthesis routes, the development of quality control methods, and the identification of reliable suppliers. Sourcing this intermediate from manufacturers who specialize in chiral synthesis and uphold stringent purity standards ensures that the integrity of the molecular structure is preserved from the intermediate stage through to the final API.

As a dedicated supplier of high-quality pharmaceutical intermediates, we recognize the critical importance of precise chemical structures and stereochemistry. Our commitment to providing (1R,2R)-1,2-Cyclohexanedicarboxylic Acid (CAS 46022-05-3) with guaranteed purity and the correct isomer configuration supports the efficient and successful manufacturing of vital APIs like Lurasidone. We are your trusted partner for essential chemical building blocks, ensuring quality and reliability in every order.